|
Nonsteroidal
Anti-Inflammatory Drugs
|
|
Home > Database
> Treatment
>
Nonsteroidal
Anti-Inflammatory Drugs
(Celebrex,
etc.)
|
|
|
Contents
|
|
|
|
Angiogenesis
|
|
|
|
Gately
S
The
contributions of cyclooxygenase-2 to tumor angiogenesis
Cancer Metastasis Rev 2000;19(1-2):19-27
|
|
Jones
MK, Wang H, Peskar BM, Levin E, Itani RM, Sarfeh IJ, Tarnawski AS
Inhibition of
angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms
and implications for cancer growth and ulcer healing
Nat
Med 1999 Dec;5(12):1418-23
|
|
|
Embryonal
Tumors |
|
|
|
Bevacizumab,
Celecoxib, Cyclophosphamide, Etoposide, Fenofibrate, Thalidomide
|
Peyrl
A, Chocholous M, Kieran MW, Azizi AA, Prucker C, Czech T, Dieckmann K,
Schmook MT, Haberler C, Leiss U, Slavc I.
Antiangiogenic metronomic therapy for children with recurrent embryonal
brain tumors.
Pediatr Blood Cancer. 2011 Dec 6;. [Epub ahead of print]
.JPG) Abstract |
.gif) Related articles
|
|
|
Glioblastoma
|
|
|
|
Amin R, Kamitani H, Sultana H, Taniura S, Islam A, Sho A,
Ishibashi M, Eling TE, Watanabe T
Aspirin
and indomethacin exhibit antiproliferative effects and induce apoptosis in T98G
human glioblastoma cells
Neurol Res. 2003
Jun;25(4):370-6
|
|
|
Goldhoff P, Warrington NM, Limbrick DD Jr, Hope
A, Woerner BM, Jackson E, Perry A, Piwnica-Worms D, Rubin JB
Targeted
Inhibition of Cyclic AMP Phosphodiesterase-4 Promotes Brain Tumor Regression
Clin
Cancer Res. 2008 Dec 1;14(23):7717-7725
Abstract
|
|
|
Grossman SA, Olson J, Batchelor T, Peereboom D,
Lesser G, Desideri S, Ye X, Hammour T, Supko JG
Effect of phenytoin on celecoxib pharmacokinetics in patients with
glioblastoma
Neuro Oncol. 2008 Feb 20; [Epub ahead of print]
Abstract
|
|
|
Kesari S, Schiff D, Henson JW, Muzikansky A, Gigas DC, Doherty L, Batchelor
TT, Longtine JA, Ligon KL, Weaver S, Laforme A, Ramakrishna N, Black PM,
Drappatz J, Ciampa A, Folkman J, Kieran M, Wen PY.
Phase
II study of temozolomide, thalidomide, and celecoxib for newly
diagnosed glioblastoma in adults.
Neuro Oncol. 2008 Jun;10(3):300-8.
Epub 2008 Apr 10.
Abstract |
.png)
Reprint |
Related articles
|
|
|
Levin VA, Giglio P, Puduvalli VK, Jochec J, Groves MD, Yung WK, Hess K.
Combination
chemotherapy with 13-cis-retinoic acid and celecoxib in the treatment
of glioblastoma multiforme.
J Neurooncol.
2006 May;78(1):85-90. Epub 2005 Nov 29.
Abstract |
Reprint |
Related articles
|
|
|
Sareddy GR, Geeviman K, Ramulu C, Babu PP.
The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth
and induces apoptosis of human glioblastoma cells via the NF-κB
pathway.
J Neurooncol.
2011 Aug 17. [Epub ahead of print]
Abstract |
Related articles
|
|
|
Scheda A, Finjap JK, Tuettenberg J, Brockmann MA, Hochhaus A, Hofheinz R,
Lohr F, Wenz F.
Efficacy of different regimens of adjuvant radiochemotherapy for
treatment of glioblastoma.
Tumori. 2007 Jan-Feb;93(1):31-6.
Abstract |
Reprint |
Related articles
|
|
|
Stockhammer F, Misch M, Koch A, Czabanka M, Plotkin M,
Blechschmidt C, Tuettenberg J, Vajkoczy P.
Continuous low-dose temozolomide and celecoxib in recurrent glioblastoma
J Neurooncol. 2010 Dec;100(3):407-15. Epub 2010 May 6.
Abstract
|
Reprint
| Related
articles
|
|
|
Seiz
M, Nölte I, Pechlivanis I, Freyschlag CF, Schmieder K, Vajkoczy P,
Tuettenberg J.
Far-distant metastases along the CSF pathway of glioblastoma multiforme
during continuous low-dose chemotherapy with temozolomide and celecoxib
Neurosurg Rev. 2010 Mar 20;. [Epub ahead of print]
Abstract
|
|
|
Tuettenberg J, Grobholz R, Korn T, Wenz F, Erber R, Vajkoczy P.
Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as
an antiangiogenic therapy of glioblastoma multiforme.
J
Cancer Res Clin Oncol. 2005 Jan;131(1):31-40. Epub 2004 Sep 28.
Abstract |
Related articles
|
|
|
Wakimoto N, Wolf I, Yin D, O'Kelly J, Akagi T,
Abramovitz L, Black KL, Tai HH, Koeffler HP.
Nonsteroidal anti-inflammatory drugs suppress glioma via
15-hydroxyprostaglandin dehydrogenase
Cancer Res. 2008 Sep 1;68(17):6978-86
Abstract |
Reprint
|
|
|
Gliomas
|
|
|
|
|
Kesari S, Schiff D, Doherty L, Gigas DC, Batchelor TT, Muzikansky A, O'Neill
A, Drappatz J, Chen-Plotkin AS, Ramakrishna N, Weiss SE, Levy B, Bradshaw J,
Kracher J, Laforme A, Black PM, Folkman J, Kieran M, Wen PY.
Phase
II study of metronomic chemotherapy for recurrent malignant gliomas in
adults.
Neuro Oncol. 2007 Jul;9(3):354-63.
Epub 2007 Apr 23.
Abstract |
Reprint |
Related articles
|
|
|
Pannullo
SC, Burton
J, Serventi
J, Stieg
P, Subramanian
H, Elsoueidi
R, El-Jassous
I, Balmaceda
C.
Phase I/II trial of twice-daily
temozolomide and celecoxib for treatment of relapsed malignant glioma: Final
data
J Clin Oncol. 2006 ASCO Annual Meeting Proceedings (Post-Meeting Edition).
Vol 24, No 18S (June 20 Supplement), 2006: 1519
Abstract
|
|
|
S. Pannullo, S. Hariharan, J.
Serventi, R. Hayes, C. Balmaceda, J. Burton
Phase I/II trial of a twice-daily
regimen of temozolomide and celecoxib for treatment of relapsed/refractory
glioblastoma multiforme and anaplastic astrocytoma
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1549
|
|
|
S.
Pannullo, J. V. Serventi, C. Balmaceda, J. Burton
Temozolomide
plus celecoxib for treatment of malignant gliomas
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No.
455
|
|
|
Reardon DA, Quinn JA, Vredenburgh J, Rich JN, Gururangan S, Badruddoja M,
Herndon JE 2nd, Dowell JM, Friedman AH, Friedman HS.
Phase
II trial of irinotecan plus celecoxib in adults with recurrent
malignant glioma.
Cancer. 2005 Jan 15;103(2):329-38.
Abstract |
Reprint |
Related articles
|
|
|
Xu K, Gao H, Shu HK.
Celecoxib can induce vascular endothelial growth factor expression and
tumor angiogenesis.
Mol Cancer Ther. 2011 Jan;10(1):138-47.
Abstract
|
Related articles
|
|
|
Medulloblastoma
|
|
|
|
Celecoxib,
Cytarabine, Etoposide, Thalidomide
|
Nygaard
R, Kivivuori SM.
Treatment for recurrent
medulloblastoma with intrathecal liposomal cytarabine and systemic
metronomic combination therapy.
Anticancer Drugs. 2011 Dec 12;.
[Epub ahead of print]
Abstract |
Related articles
|
|
|
Metastatic
Tumors
|
|
|
|
Leandro C. A. Cerchietti,
Marcelo R. Bonomi, Alfredo H. Navigante, Monica A. Castro, Maria E. Cabalar
and Berta M. C. Roth
Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as
a radiation sensitizer in patients with unresectable brain metastases
Journal
of Neuro-Oncology, 71(1):
73-81, January 2005. (Abstract+)
|
|
|
Non-Nervous
System T.
|
|
|
|
Arber N,
DuBois RN
Nonsteroidal
anti-inflammatory drugs and prevention of colorectal cancer
Curr Gastroenterol Rep 1999 Oct;1(5):441-8
|
|
Alshafie
GA, Abou-Issa HM, Seibert K, Harris RE
Chemotherapeutic
evaluation of Celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor
model
Oncol
Rep 2000 Nov-Dec;7(6):1377-81
|
|
|
Nasser
K Altorki, Roger S Keresztes, Jeffrey L Port, Douglas B Flieder, Cathy A
Ferrara, Mark W Pasmantier, Daniel M Libby, David Yankelevitz, Andrew J
Dannenberg
Celecoxib (Celebrex), a selective COX-2 inhibitor,
enhances the response to preoperative paclitaxel/carboplatin in early stage
non-small cell lung cancer
ASCO
Proceedings, 2002 Annual Meeting, Abstract No. 101
|
|
